BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25051361)

  • 1. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle.
    Caraballo JM; Acosta JC; Cortés MA; Albajar M; Gómez-Casares MT; Batlle-López A; Cuadrado MA; Onaindia A; Bretones G; Llorca J; Piris MA; Colomer D; León J
    Oncotarget; 2014 Jul; 5(13):4694-708. PubMed ID: 25051361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
    Kim SS; Meitner P; Konkin TA; Cho YS; Resnick MB; Moss SF
    Mod Pathol; 2006 Jan; 19(1):49-58. PubMed ID: 16118628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.
    Fagan-Solis KD; Pentecost BT; Gozgit JM; Bentley BA; Marconi SM; Otis CN; Anderton DL; Schneider SS; Arcaro KF
    J Cell Physiol; 2014 Sep; 229(9):1160-9. PubMed ID: 24443386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients.
    Hafez MM; Alhoshani AR; Al-Hosaini KA; Alsharari SD; Al Rejaie SS; Sayed-Ahmed MM; Al-Shabanah OA
    Asian Pac J Cancer Prev; 2015; 16(14):5807-15. PubMed ID: 26320455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.).
    Gómez-Casares MT; García-Alegria E; López-Jorge CE; Ferrándiz N; Blanco R; Alvarez S; Vaqué JP; Bretones G; Caraballo JM; Sánchez-Bailón P; Delgado MD; Martín-Perez J; Cigudosa JC; León J
    Oncogene; 2013 Apr; 32(17):2239-46. PubMed ID: 22710719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korean red ginseng extract induces proliferation to differentiation transition of human acute promyelocytic leukemia cells via MYC-SKP2-CDKN1B axis.
    Jo S; Lee H; Kim S; Lee CH; Chung H
    J Ethnopharmacol; 2013 Nov; 150(2):700-7. PubMed ID: 24095829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
    Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
    Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells.
    Egozi D; Shapira M; Paor G; Ben-Izhak O; Skorecki K; Hershko DD
    FASEB J; 2007 Sep; 21(11):2807-17. PubMed ID: 17475922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
    Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
    Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL.
    Halina A; Artur P; Barbara MK; Joanna S; Anna D
    Folia Histochem Cytobiol; 2010 Dec; 48(4):534-41. PubMed ID: 21478095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia.
    Vrhovac R; Delmer A; Tang R; Marie JP; Zittoun R; Ajchenbaum-Cymbalista F
    Blood; 1998 Jun; 91(12):4694-700. PubMed ID: 9616167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells.
    Kullmann MK; Grubbauer C; Goetsch K; Jäkel H; Podmirseg SR; Trockenbacher A; Ploner C; Cato AC; Weiss C; Kofler R; Hengst L
    Cell Cycle; 2013 Aug; 12(16):2625-35. PubMed ID: 23907123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.